EMERYVILLE, California--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies for the treatment of solid tumors, today announced the initiation of a Phase I/II clinical trial of.
Read article AstraZeneca's Imfinzi (durvalumab) has been approved in China for the first-line treatment of adult patients with extensive small cell lung cancer (ES-SCLC), in combination with standard platinum chemotherapy.
Breadcrumb Trail Links Local news Author of the article: Elizabeth Payne • Ottawa burger Publication date: 01 Nov 2016 • Nov 1, 2016 • 5 minutes reading • Join the.
The American Cancer Society recently reported a decline in the overall cancer death rate in the US, with a overall drop of 29% in cancer deaths from 1991 to 2017..
LONDON--(BUSINESS WIRE)--A report published today, 'Lung cancer screening: the cost of doing nothing', shows that screening for lung cancer offers a crucial opportunity to significantly improve survival.1 According to the.
Austin, Texas, July 2, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, announced today that it will present new data on its.